ImmunityBio (IBRX) Research & Development (2014 - 2026)
ImmunityBio (IBRX) posted Research & Development of $60.82 million for Q2 2026, up 10.1% from $55.24 million a year earlier but down 10.6% from the prior quarter.
Powered by 
Analysis
ImmunityBio (IBRX) Research & Development (2014 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Research & Development at ImmunityBio was $243.89 million, up 29.0% year-over-year; for FY2025, it came in at $218.56 million, up 14.9% from FY2024.
- Annual Research & Development shows a five-year compound annual growth rate of 9.4% (FY2020 to FY2025).
- In prior years, ImmunityBio's Research & Development was $190.14 million in FY2024 (-18.2%), $232.37 million in FY2023 (-6.4%), $248.15 million in FY2022 (+26.6%) and $195.96 million in FY2021 (+40.5%).
- Quarterly Research & Development has run from a low of $35.22 million in Q4 2024 to a high of $79.26 million in Q1 2023 over five years.
- On a year-over-year basis, Research & Development has increased in each of the last five quarters, with growth averaging 13.1% over the last eight quarters.
- The strongest year-over-year quarter for Research & Development in the past five years was Q4 2025, with growth of 81.3%; the weakest was Q1 2024, with a decline of 32.7%.
- According to Business Quant data, Research & Development for the three prior quarters was $67.99 million (Q1 2026), $63.86 million (Q4 2025) and $51.23 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | ImmunityBio | 8.97 Bn | 7.74 Bn | 50.94 Mn | 60.82 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 60.82 Mn |
| Mar 31, 2026 | 67.99 Mn |
| Dec 31, 2025 | 63.86 Mn |
| Sep 30, 2025 | 51.23 Mn |
| Jun 30, 2025 | 55.24 Mn |
| Mar 31, 2025 | 48.23 Mn |
| Dec 31, 2024 | 35.22 Mn |
| Sep 30, 2024 | 50.44 Mn |
| Jun 30, 2024 | 51.13 Mn |
| Mar 31, 2024 | 53.35 Mn |
| Dec 31, 2023 | 51.53 Mn |
| Sep 30, 2023 | 48.40 Mn |
| Jun 30, 2023 | 53.17 Mn |
| Mar 31, 2023 | 79.26 Mn |
| Dec 31, 2022 | 58.08 Mn |
| Sep 30, 2022 | 71.61 Mn |
| Jun 30, 2022 | 63.08 Mn |
| Mar 31, 2022 | 55.38 Mn |
| Dec 31, 2021 | 51.75 Mn |
| Sep 30, 2021 | 49.28 Mn |
API Access
ImmunityBio Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=IBRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "IBRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=IBRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();